| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 1621 |
| 1 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1298 |
| 2 | TERIPARATIDE | 966 |
| 3 | ALENDRONATE SODIUM | 848 |
| 4 | TENOFOVIR DISOPROXIL FUMARATE | 803 |
| 5 | METHOTREXATE SODIUM | 719 |
| 6 | ROMOSOZUMAB-AQQG | 676 |
| 7 | METHOTREXATE | 644 |
| 8 | PREDNISONE | 639 |
| 9 | ABATACEPT | 571 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIBUCAINE 1% | 6 | 0.0522 |
| 1 | ROMOSOZUMAB-AQQG | 676 | 0.0474 |
| 2 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 304 | 0.0339 |
| 3 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 321 | 0.0320 |
| 4 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR DISOPROXIL FUMARATE | 210 | 0.0312 |
| 5 | SILTUXIMAB | 20 | 0.0308 |
| 6 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 342 | 0.0299 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 1298 | 0.0286 |
| 8 | DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE | 73 | 0.0265 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 67 | 0.0242 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 1621 |
| 1 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1611 |
| 2 | Corticosteroid [EPC] | 1268 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1245 |
| 4 | Parathyroid Hormone Analog [EPC] | 966 |
| 5 | Benzodiazepine [EPC] | 677 |
| 6 | Thalidomide Analog [EPC] | 670 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 658 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 648 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 642 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 20 | 0.0308 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 40 | 0.0176 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1611 | 0.0146 |
| 3 | Antidiarrheal [EPC] | 3 | 0.0126 |
| 4 | Calcitonin [EPC] | 36 | 0.0115 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 642 | 0.0106 |
| 6 | Parathyroid Hormone Analog [EPC] | 966 | 0.0086 |
| 7 | RANK Ligand Inhibitor [EPC] | 1621 | 0.0080 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 69 | 0.0067 |
| 9 | Erythroid Maturation Agent [EPC] | 17 | 0.0065 |